Combining Immunotherapy with Transarterial Radioembolization

Hepatocellular carcinoma (HCC) has a high mortality rate due to the diagnosis of patients at advanced stages and ineffective systemic therapies. Immunotherapy is considered a new treatment option for unresectable HCC alternatives to the limitations of conventional cytotoxic chemotherapy. In this cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaban Genc, Zeynep Ceren, Soydemır, Efe, Ersoy, Seval Ay, Ones, Tunc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348490/
https://www.ncbi.nlm.nih.gov/pubmed/37456187
http://dx.doi.org/10.4103/ijnm.ijnm_180_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348490/
https://www.ncbi.nlm.nih.gov/pubmed/37456187
http://dx.doi.org/10.4103/ijnm.ijnm_180_22

Ejemplares similares